149 related articles for article (PubMed ID: 10435491)
1. Penicillamine as a controversial treatment for Wilson's disease.
LeWitt PA
Mov Disord; 1999 Jul; 14(4):555-6. PubMed ID: 10435491
[No Abstract] [Full Text] [Related]
2. Penicillamine: the treatment of first choice for patients with Wilson's disease.
Walshe JM
Mov Disord; 1999 Jul; 14(4):545-50. PubMed ID: 10435489
[No Abstract] [Full Text] [Related]
3. [Treatment of Wilson's disease].
Pépin B; Barraine R
Cah Coll Med Hop Paris; 1968 Feb; 9(2):184-7. PubMed ID: 5745277
[No Abstract] [Full Text] [Related]
4. Hypothyroidism and dyshormonogenesis induced by D-penicillamine in children with Wilson's disease and healthy infants born to a mother with Wilson's disease.
Hanukoglu A; Curiel B; Berkowitz D; Levine A; Sack J; Lorberboym M
J Pediatr; 2008 Dec; 153(6):864-6. PubMed ID: 19014823
[TBL] [Abstract][Full Text] [Related]
5. Patient with late-onset Wilson's disease: deterioration with penicillamine.
Sohtaoglu M; Ergin H; Ozekmekçi S; Gökdemir S; Sonsuz A; Arici C
Mov Disord; 2007 Jan; 22(2):290-1. PubMed ID: 17083099
[No Abstract] [Full Text] [Related]
6. Wilson's disease and pregnancy.
Sternlieb I
Hepatology; 2000 Feb; 31(2):531-2. PubMed ID: 10655282
[No Abstract] [Full Text] [Related]
7. Brief observations on the management of Wilson's disease.
Walshe JM
Proc R Soc Med; 1977; 70 Suppl 3(Suppl 3):1-3. PubMed ID: 122651
[No Abstract] [Full Text] [Related]
8. Copper chelation in patients with Wilson's disease. A comparison of penicillamine and triethylene tetramine dihydrochloride.
Walshe JM
Q J Med; 1973 Jul; 42(167):441-52. PubMed ID: 4728043
[No Abstract] [Full Text] [Related]
9. Early onset of nephrotic syndrome after treatment with D-penicillamine in a patient with Wilson's disease.
Siafakas CG; Jonas MM; Alexander S; Herrin J; Furuta GT
Am J Gastroenterol; 1998 Dec; 93(12):2544-6. PubMed ID: 9860423
[TBL] [Abstract][Full Text] [Related]
10. Epileptic status immediately after initiation of D-penicillamine therapy in a patient with Wilson's disease.
Berger B; Mader I; Damjanovic K; Niesen WD; Stich O
Clin Neurol Neurosurg; 2014 Dec; 127():122-4. PubMed ID: 25459257
[No Abstract] [Full Text] [Related]
11. [Pathogenesis and treatment of Wilson's disease].
Nagy J; Vincze Z; Folhoffer A; Horváth A; Csák T; Zelkó R
Acta Pharm Hung; 2003; 73(4):237-41. PubMed ID: 15279036
[TBL] [Abstract][Full Text] [Related]
12. [Anatomo-clinical study of a case of Wilson's disease treated with chelating agents for 5 years].
Boudin G; Pépin B; Milhaud M; Jérome H; Pacilly A
Rev Neurol (Paris); 1968 Jan; 118(1):27-35. PubMed ID: 5697565
[No Abstract] [Full Text] [Related]
13. Treatment of Wilson's disease: what are the relative roles of penicillamine, trientine, and zinc supplementation?
Schilsky ML
Curr Gastroenterol Rep; 2001 Feb; 3(1):54-9. PubMed ID: 11177695
[TBL] [Abstract][Full Text] [Related]
14. Stereotypies in Wilson's disease.
Yorio AA; Mesri JC; Pagano MA; Lera G
Mov Disord; 1997 Jul; 12(4):614-6. PubMed ID: 9251089
[No Abstract] [Full Text] [Related]
15. Penicillamine induced pseudo-pseudoxanthoma elasticum in a patient with Wilson's disease, which role plays the hepatologist?
Ibáñez-Samaniego L; Ochoa-Palominos A; Catalina-Rodríguez MV; Salcedo-Plaza M; Clemente-Ricote G
Rev Esp Enferm Dig; 2015 Mar; 107(3):190-1. PubMed ID: 25733050
[No Abstract] [Full Text] [Related]
16. Effect of penicillamine and zinc on iron metabolism in Wilson's disease.
Medici V; Di Leo V; Lamboglia F; Bowlus CL; Tseng SC; D'Incà R; Irato P; Burra P; Martines D; Sturniolo GC
Scand J Gastroenterol; 2007 Dec; 42(12):1495-500. PubMed ID: 17994470
[TBL] [Abstract][Full Text] [Related]
17. [Biochemical bases and therapeutic possibilities of K. Wilson's hepatolenticular degeneration].
Grau-Veciana JM; Barraquer-Bordas L
Arch Neurobiol (Madr); 1967; 30(3):251-74. PubMed ID: 4970136
[No Abstract] [Full Text] [Related]
18. [Pregnancy, labor and early puerperium in a patient with Wilson's disease].
Hlinst'ák K; Borovský M; Hlinst'áková S
Ceska Gynekol; 1999 Jun; 64(3):198-200. PubMed ID: 10568054
[TBL] [Abstract][Full Text] [Related]
19. Pencillamine-induced elastosis perforans serpiginosa and cutis laxa in Wilson's disease.
Hill VA; Seymour CA; Mortimer PS
Br J Dermatol; 2000 Mar; 142(3):560-1. PubMed ID: 10777259
[No Abstract] [Full Text] [Related]
20. Discontinuation of penicillamine in the absence of alternative orphan drugs (trientine-zinc): a case of decompensated liver cirrhosis in Wilson's disease.
Ping CC; Hassan Y; Aziz NA; Ghazali R; Awaisu A
J Clin Pharm Ther; 2007 Feb; 32(1):101-7. PubMed ID: 17286794
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
